By Gina Kolata The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide ...
Meanwhile, Alnylam Pharmaceuticals’ growth was primarily due to its RNA interference drug vutrisiran having met its primary endpoint of reduced all-cause mortality and recurrent cardiovascular events ...
The top 20 biopharmaceutical companies demonstrated ... fuelled by robust pipeline progress and the US Food and Drug Administration (FDA) approval of its antipsychotic drug Cobenfy for the ...
Federal, state and local law enforcement officials recently announced the unsealing of a superseding indictment that charged 20 members of a Drug Trafficking Operation (DTO) allegedly operating in ...
as the results appear to be at the lower end of Wall Street's lofty expectations for the drug. Ahead of the data, several analysts said they wanted MariTide to show weight loss of at least 20% in ...